1-9 of 9
Kazuyuki Yoshizaki
Close
Sort by
Journal Articles

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

Clinical Trials & Observations
Frits van Rhee, Peter Voorhees, Angela Dispenzieri, Alexander Fosså, Gordan Srkalovic, Makoto Ide, Nikhil Munshi, Stephen Schey, Matthew Streetly, Sheila K. Pierson, Helen L. Partridge, Sudipto Mukherjee, Dustin Shilling, Katie Stone, Amy Greenway, Jason Ruth, Mary Jo Lechowicz, Shanmuganathan Chandrakasan, Raj Jayanthan, Elaine S. Jaffe, Heather Leitch, Naveen Pemmaraju, Amy Chadburn, Megan S. Lim, Kojo S. Elenitoba-Johnson, Vera Krymskaya, Aaron Goodman, Christian Hoffmann, Pier Luigi Zinzani, Simone Ferrero, Louis Terriou, Yasuharu Sato, David Simpson, Raymond Wong, Jean-Francois Rossi, Sunita Nasta, Kazuyuki Yoshizaki, Razelle Kurzrock, Thomas S. Uldrick, Corey Casper, Eric Oksenhendler, David C. Fajgenbaum
Journal: Blood
Blood (2018) 132 (20): 2115–2124.
https://doi.org/10.1182/blood-2018-07-862334
Published: 2018
Includes: Supplemental data
Journal Articles

International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease

Clinical Trials & Observations
David C. Fajgenbaum, Thomas S. Uldrick, Adam Bagg, Dale Frank, David Wu, Gordan Srkalovic, David Simpson, Amy Y. Liu, David Menke, Shanmuganathan Chandrakasan, Mary Jo Lechowicz, Raymond S. M. Wong, Sheila Pierson, Michele Paessler, Jean-François Rossi, Makoto Ide, Jason Ruth, Michael Croglio, Alexander Suarez, Vera Krymskaya, Amy Chadburn, Gisele Colleoni, Sunita Nasta, Raj Jayanthan, Christopher S. Nabel, Corey Casper, Angela Dispenzieri, Alexander Fosså, Dermot Kelleher, Razelle Kurzrock, Peter Voorhees, Ahmet Dogan, Kazuyuki Yoshizaki, Frits van Rhee, Eric Oksenhendler, Elaine S. Jaffe, Kojo S. J. Elenitoba-Johnson, Megan S. Lim
Journal: Blood
Blood (2017) 129 (12): 1646–1657.
https://doi.org/10.1182/blood-2016-10-746933
Published: 2017
Journal Articles

Suppressing Hepcidin By Tocilizumab Effectively Improve Anemia in Inflammatory Diseases: Clinical Evidence and Basic Mechanisms

Kazuyuki Yoshizaki, Soken-Nakazawa J Song, Hiroshi Kawabata
Journal: Blood
Blood (2014) 124 (21): 4006.
https://doi.org/10.1182/blood.V124.21.4006.4006
Published: 2014
Journal Articles

Analysis Of The Molecular Mechanisms Leading To Significantly Higher Serum Hepcidin and More Severe Anemia In Multicentric Castleman’s Disease (MCD) Patients Than In Rheumatoid Arthritis (RA) Patients

Soken-Nakazawa J. Song, MD, PhD, Hiroshi Kawabata, MD, PhD, Kazuyuki Yoshizaki, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2181.
https://doi.org/10.1182/blood.V122.21.2181.2181
Published: 2013
Journal Articles

Down-regulation of hepcidin resulting from long-term treatment with an anti–IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease

Clinical Trials & Observations
Soken-Nakazawa J. Song, Naohisa Tomosugi, Hiroshi Kawabata, Takayuki Ishikawa, Teppei Nishikawa, Kazuyuki Yoshizaki
Journal: Blood
Blood (2010) 116 (18): 3627–3634.
https://doi.org/10.1182/blood-2010-03-271791
Published: 2010
Includes: Supplemental data
Journal Articles

Monitoring of Serum Hepcidin-25 in Multicentric Castleman’s Disease Patients Treated with Tocilizumab, an Anti-Interleukin-6 Receptor Antibody.

Hiroshi Kawabata, MD, Naohisa Tomosugi, MD, Junya Kanda, MD, Chisaki Mizumoto, MD, Yasuhiro Tanaka, MD, Tatsuo Ichinohe, MD, Norimitsu Kadowaki, MD, Kazuyuki Yoshizaki, MD, Takayuki Ishikawa, MD, Takashi Uchiyama, MD
Journal: Blood
Blood (2007) 110 (11): 3686.
https://doi.org/10.1182/blood.V110.11.3686.3686
Published: 2007
Journal Articles

Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease

Clinical Trials & Observations
Norihiro Nishimoto, Yuzuru Kanakura, Katsuyuki Aozasa, Takeshi Johkoh, Minoru Nakamura, Shuji Nakano, Nobuaki Nakano, Yasuo Ikeda, Takeshi Sasaki, Kiyoshi Nishioka, Masamichi Hara, Hirokuni Taguchi, Yukihiko Kimura, Yoshiro Kato, Hideki Asaoku, Shunichi Kumagai, Fumio Kodama, Hideko Nakahara, Keisuke Hagihara, Kazuyuki Yoshizaki, Tadamitsu Kishimoto
Journal: Blood
Blood (2005) 106 (8): 2627–2632.
https://doi.org/10.1182/blood-2004-12-4602
Published: 2005
Journal Articles

Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy

Norihiro Nishimoto, Mitsuko Sasai, Yoshihito Shima, Masashi Nakagawa, Tomoshige Matsumoto, Toshikazu Shirai, Tadamitsu Kishimoto, Kazuyuki Yoshizaki
Journal: Blood
Blood (2000) 95 (1): 56–61.
https://doi.org/10.1182/blood.V95.1.56
Published: 2000
Journal Articles

Deficient Expression of Bruton's Tyrosine Kinase in Monocytes From X-Linked Agammaglobulinemia as Evaluated by a Flow Cytometric Analysis and Its Clinical Application to Carrier Detection

Takeshi Futatani, Toshio Miyawaki, Satoshi Tsukada, Shoji Hashimoto, Toshio Kunikata, Shigeyuki Arai, Masashi Kurimoto, Yo Niida, Hiroshi Matsuoka, Yukio Sakiyama, Tsutomu Iwata, Shigeru Tsuchiya, Osamu Tatsuzawa, Kazuyuki Yoshizaki, Tadamitsu Kishimoto
Journal: Blood
Blood (1998) 91 (2): 595–602.
https://doi.org/10.1182/blood.V91.2.595
Published: 1998